Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome arising from lipid
metabolic imbalance, with its prevalence increasing globally. In this study, we observed a …

Nonalcoholic fatty liver disease (NAFLD) has become a worldwide epidemic. A large and
growing unmet therapeutic need has inspired numerous studies in the field. Integrating the …

Background and Aims Although knowledge regarding the pathogenesis of nonalcoholic fatty
liver disease (NAFLD) has profoundly grown in recent decades, the internal restrictive …

Obesity is a calorie‐excessive state associated with high risk of diabetes, atherosclerosis,
and certain types of tumors. Obesity may induce inflammation and insulin resistance (IR) …

Objective Non-alcoholic fatty liver disease (NAFLD) is an aberrant lipid metabolism disease.
Hypoxia inducible factor-1 (HIF-1α) is a transcription factor which plays an important part in …

Inflammation has profound but poorly understood effects on metabolism, especially in the
context of obesity and nonalcoholic fatty liver disease (NAFLD). Here, we report that hepatic …

Obesity and related metabolic diseases associated with chronic low‐grade inflammation
greatly compromise human health. Previous observations on the roles of interferon …

We aimed to illustrate the regulatory effect of miR-18 on the onset of non-alcoholic fatty liver
disease (NAFLD). MiR-18 level in liver tissues collected from NAFLD patients and mice was …

An association between increased insulin‐like growth factor binding protein‐7 (IGFBP 7)
expression and insulin resistance in metabolic diseases has been reported. However, the …

Non-alcoholic fatty liver disease (NAFLD) the hepatic manifestation of the metabolic
syndrome, remains without approved pharmacological treatment, with lifestyle modifications …